Issuer:
|
Celgene Corporation | |
Expected Ratings (Moody’s / S&P)*:
|
Baa2/BBB+ | |
Type of Transaction:
|
SEC-Registered | |
Trade Date:
|
October 4, 2010 | |
Expected Settlement Date:
|
October 7, 2010 (T+3) | |
Joint Book-Running Managers:
|
Citigroup Global Markets Inc. | |
| J.P. Morgan Securities LLC | ||
| Morgan Stanley & Co. Incorporated | ||
Title:
|
2.450% Notes due 2015 | |
| 3.950% Notes due 2020 | ||
| 5.700% Notes due 2040 | ||
Size:
|
2015 Notes: $500,000,000 | |
| 2020 Notes: $500,000,000 | ||
| 2040 Notes: $250,000,000 | ||
Maturity Date:
|
2015 Notes: October 15, 2015 | |
| 2020 Notes: October 15, 2020 | ||
| 2040 Notes: October 15, 2040 | ||
Coupon (Interest Rate):
|
2015 Notes: 2.450% per annum | |
| 2020 Notes: 3.950% per annum | ||
| 2040 Notes: 5.700% per annum | ||
Price to Public:
|
2015 Notes: 99.854% | |
| 2020 Notes: 99.745% | ||
| 2040 Notes: 99.813% | ||
Yield to Maturity:
|
2015 Notes: 2.481% | |
| 2020 Notes: 3.981% | ||
| 2040 Notes: 5.713% | ||
Spread to Benchmark Treasury:
|
2015 Notes: + 125 basis points | |
| 2020 Notes: + 150 basis points | ||
| 2040 Notes: + 200 basis points | ||
Benchmark Treasury:
|
2015 Notes: 1.250% due September 2015 | |
| 2020 Notes: 2.625% due August 2020 | ||
| 2040 Notes: 4.375% due May 2040 | ||
Benchmark Treasury Yield:
|
2015 Notes: 1.231% | |
| 2020 Notes: 2.481% | ||
| 2040 Notes: 3.713% | ||
Interest Payment Dates:
|
April 15 and October 15, commencing April 15, 2011 | |
Optional Redemption
|
2015 Notes: T + 20 basis points | |
| 2020 Notes: T + 25 basis points | ||
| 2040 Notes: T + 30 basis points | ||
CUSIP / ISIN:
|
2015 Notes: 151020 AD6 / US151020AD69 | |
| 2020 Notes: 151020 AE4 / US151020AE43 | ||
| 2040 Notes: 151020 AF1 / US151020AF18 |
| * | Note: A Security rating is not a recommendation to buy, sell or hold securities, and may be subject to revision or withdrawal at any time. |